Apple [AAPL] vs Zepp Health [ZEPP] Detailed Stock Comparison
Apple
NASDAQ
Loading...
Zepp Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Apple wins in 10 metrics, Zepp Health wins in 8 metrics, with 0 ties. Apple appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Apple | Zepp Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.66 | -2.80 | Zepp Health |
| Price-to-Book Ratio | 45.67 | 0.81 | Zepp Health |
| Debt-to-Equity Ratio | 154.49 | 46.23 | Zepp Health |
| PEG Ratio | 24.35 | -1,300.00 | Zepp Health |
| EV/EBITDA | 21.52 | -66.54 | Zepp Health |
| Profit Margin (TTM) | 24.30% | -44.54% | Apple |
| Operating Margin (TTM) | 29.99% | -47.68% | Apple |
| EBITDA Margin (TTM) | 29.99% | N/A | N/A |
| Return on Equity | 149.81% | -28.56% | Apple |
| Return on Assets (TTM) | 24.55% | -5.65% | Apple |
| Free Cash Flow (TTM) | $108.81B | $-25.88M | Apple |
| Dividend Yield | 0.51% | N/A | N/A |
| 1-Year Return | -7.95% | 507.48% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 7.35 | 1.03 | Zepp Health |
| Enterprise Value | $3,049.72B | $3.02B | Apple |
| EV/Revenue Ratio | 7.46 | 16.66 | Apple |
| Gross Profit Margin (TTM) | 46.49% | 37.27% | Apple |
| Revenue per Share (TTM) | $27 | $11 | Apple |
| Earnings per Share (Diluted) | $6.60 | $-4.96 | Apple |
| Beta (Stock Volatility) | 1.20 | 0.85 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Apple vs Zepp Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Apple | -2.50% | -5.38% | -2.62% | -5.13% | -11.24% | -17.01% |
| Zepp Health | -3.42% | 16.80% | 360.99% | 381.48% | 357.75% | 352.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Apple | -7.95% | 22.39% | 82.14% | 600.76% | 2,078.47% | 13,041.56% |
| Zepp Health | 507.48% | 92.31% | -71.37% | -71.44% | -71.44% | -71.44% |
Performance & Financial Health Analysis: Apple vs Zepp Health
| Metric | AAPL | ZEPP |
|---|---|---|
| Market Information | ||
| Market Cap | $3.00T | $186.79M |
| Market Cap Category | Mega cap | Micro cap |
| 10 Day Avg. Volume | 55,084,450 | 297,500 |
| 90 Day Avg. Volume | 54,878,510 | 1,000,603 |
| Last Close | $202.38 | $13.00 |
| 52 Week Range | $169.21 - $260.10 | $2.06 - $15.85 |
| % from 52W High | -22.19% | -17.98% |
| All-Time High | $260.10 (Dec 23, 2024) | $81.00 (Feb 15, 2021) |
| % from All-Time High | -22.19% | -83.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | -0.03% |
| Quarterly Earnings Growth | 0.09% | 5.89% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | -0.45% |
| Operating Margin (TTM) | 0.30% | -0.48% |
| Return on Equity (TTM) | 1.50% | -0.29% |
| Debt to Equity (MRQ) | 154.49 | 46.23 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.43 | $16.15 |
| Cash per Share (MRQ) | $3.73 | $0.34 |
| Operating Cash Flow (TTM) | $108.56B | $-25,970,000 |
| Levered Free Cash Flow (TTM) | $94.87B | $-137,800,733 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.51% | N/A |
| Last 12-Month Dividend | $1.01 | $0.00 |
Valuation & Enterprise Metrics Analysis: Apple vs Zepp Health
| Metric | AAPL | ZEPP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.66 | -2.80 |
| Forward P/E | 24.35 | -1,300.00 |
| PEG Ratio | 24.35 | -1,300.00 |
| Price to Sales (TTM) | 7.35 | 1.03 |
| Price to Book (MRQ) | 45.67 | 0.81 |
| Market Capitalization | ||
| Market Capitalization | $3.00T | $186.79M |
| Enterprise Value | $3.05T | $3.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.46 | 16.66 |
| Enterprise to EBITDA | 21.52 | -66.54 |
| Risk & Other Metrics | ||
| Beta | 1.20 | 0.85 |
| Book Value per Share (MRQ) | $4.43 | $16.15 |
Financial Statements Comparison: Apple vs Zepp Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AAPL | ZEPP |
|---|---|---|
| Revenue/Sales | $95.36B | $38.54M |
| Cost of Goods Sold | $50.49B | $24.18M |
| Gross Profit | $44.87B | $14.36M |
| Research & Development | $8.55B | $12.38M |
| Operating Income (EBIT) | $29.59B | $-18.38M |
| EBITDA | $32.25B | $-17.79M |
| Pre-Tax Income | $29.31B | $-19.27M |
| Income Tax | $4.53B | $110,000 |
| Net Income (Profit) | $24.78B | $-19.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AAPL | ZEPP |
|---|---|---|
| Cash & Equivalents | $28.16B | $76.43M |
| Total Current Assets | $118.67B | $242.46M |
| Total Current Liabilities | $144.57B | $212.34M |
| Long-Term Debt | $78.57B | $71.16M |
| Total Shareholders Equity | $66.80B | $232.04M |
| Retained Earnings | $-15.55B | $8.88M |
| Property, Plant & Equipment | N/A | $9.56M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AAPL | ZEPP |
|---|---|---|
| Operating Cash Flow | $23.95B | $-14.63M |
| Capital Expenditures | $-3.07B | $-2.92M |
| Free Cash Flow | $20.88B | $-16.89M |
| Debt Repayment | $976.00M | N/A |
| Common Stock Repurchase | $-25.90B | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AAPL | ZEPP |
|---|---|---|
| Shares Short | 93.95M | 308,546 |
| Short Ratio | 1.74 | 0.25 |
| Short % of Float | 0.01% | 0.05% |
| Average Daily Volume (10 Day) | 55,084,450 | 297,500 |
| Average Daily Volume (90 Day) | 54,878,510 | 1,000,603 |
| Shares Outstanding | 15.12B | 231.98M |
| Float Shares | 14.81B | 98.58M |
| % Held by Insiders | 0.02% | 0.06% |
| % Held by Institutions | 0.63% | 0.26% |
Dividend Analysis & Yield Comparison: Apple vs Zepp Health
| Metric | AAPL | ZEPP |
|---|---|---|
| Last 12-Month Dividend | $1.01 | $0.00 |
| Last 12-Month Dividend Yield | 0.51% | N/A |
| 3-Year Avg Annual Dividend | $0.97 | $0.00 |
| 3-Year Avg Dividend Yield | 0.13% | N/A |
| 3-Year Total Dividends | $2.91 | $0.00 |
| Ex-Dividend Date | May 12, 2025 | N/A |